📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Montelukast reduces grey matter abnormalities and functional deficits in a mouse model of inflammation-induced encephalopathy of prematurity. (2022)

First Author: Yates AG

Attributed to: The Developing Brain funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s12974-022-02625-5

PubMed Identifier: 36309753

Publication URI: http://europepmc.org/abstract/MED/36309753

Type: Journal Article/Review

Volume: 19

Parent Publication: Journal of neuroinflammation

Issue: 1

ISSN: 1742-2094